MY128859A - Compounds for the treatment of cancer - Google Patents

Compounds for the treatment of cancer

Info

Publication number
MY128859A
MY128859A MYPI20012836A MY128859A MY 128859 A MY128859 A MY 128859A MY PI20012836 A MYPI20012836 A MY PI20012836A MY 128859 A MY128859 A MY 128859A
Authority
MY
Malaysia
Prior art keywords
compounds
doxorubicin
cancer
treatment
potency
Prior art date
Application number
Inventor
Strelchenok Oleg
Original Assignee
Ardenia Investments Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardenia Investments Ltd filed Critical Ardenia Investments Ltd
Priority to MYPI20012836 priority Critical patent/MY128859A/en
Publication of MY128859A publication Critical patent/MY128859A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

IT IS SHOWN THAT THE POTENCY OF ANTI-CANCER DRUGS, HERE EXEMPLIFIED BY DOXORUBICIN, CAN BE INCREASED BY THE USE OF POLYUNSATURATED FATTY ACID AMIDES AND IN PARTICULAR SPECIFIC COMBINATIONS OF SUCH COMPOUNDS, FORMING COMPLEXES WITH DOXORUBICIN. FURTHER, A MODIFIED FORM OF DOXORUBICIN IS PRESENTED.
MYPI20012836 2001-06-15 2001-06-15 Compounds for the treatment of cancer MY128859A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20012836 MY128859A (en) 2001-06-15 2001-06-15 Compounds for the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20012836 MY128859A (en) 2001-06-15 2001-06-15 Compounds for the treatment of cancer

Publications (1)

Publication Number Publication Date
MY128859A true MY128859A (en) 2007-02-28

Family

ID=47289708

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20012836 MY128859A (en) 2001-06-15 2001-06-15 Compounds for the treatment of cancer

Country Status (1)

Country Link
MY (1) MY128859A (en)

Similar Documents

Publication Publication Date Title
GB0314624D0 (en) Inflammatory disease treatment
PL365783A1 (en) 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
UA88464C2 (en) Method of topical methadone administration providing systemic effect
DE60335797D1 (en) SOLUBLE FORMULATIONS CONTAINING MONOMERIC INSULIN AND ACYLATED INSULIN
DK1296670T3 (en) Therapeutic fatty acid combinations
NZ540385A (en) Use of 1-oxo-2-(2, 6-dioxopiperidin-3-yl)-4-methylisoindoline in the manufacture of a medicamnent for treatment of brain cancer
ZA200301269B (en) Prodrugs of betulinic acid derivatives for the treatment of cancer and HIV.
MXPA03008419A (en) Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof.
WO2000006134A3 (en) Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity
GEP20053510B (en) Substituted Pyrrolopyridinone Derivatives Useful as Phosphodiesterase Inhibitors
MY137828A (en) Keratinocytes which may be used as a biologically active substances for the treatment of wounds
MXPA03003511A (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid.
IL150528A0 (en) Ibuprofen containing active agent preparation
PL369148A1 (en) Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment
GB2431346C (en) A combination composition comprising paracetamol and ibuprofen
EP1359909A4 (en) Anticancer treatment using triptolide prodrugs
WO2000042832A3 (en) New compounds for the treatment of cancer
PL373049A1 (en) Ruthenium anticancer complexes
MXPA04001655A (en) Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof.
TW200501970A (en) Use of PVP-iodine liposomes for treatment of acne
IL160722A0 (en) Aryloxypropylamines as chemosensitizing agents in the treatment of cancer
TW200509987A (en) Use of PVP-iodine liposomes for treatment of Herpes
GB0326518D0 (en) Anti-cancer compounds
EP1374873B8 (en) The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for supressing side-effect of radiotherapy and chemotherapy
TW200503778A (en) Use of PVP-iodine liposomes for treatment of atopic dermatitis